Ortivus AB
STO:ORTI B
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.4
3.8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Ortivus AB
Cost of Revenue
Ortivus AB
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
Ortivus AB
STO:ORTI B
|
Cost of Revenue
-kr53.2m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
RaySearch Laboratories AB (publ)
STO:RAY B
|
Cost of Revenue
-kr106.6m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
ContextVision AB
OSE:CONTX
|
Cost of Revenue
-kr4.1m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-8%
|
|
|
M
|
Mentice AB
STO:MNTC
|
Cost of Revenue
-kr37.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Sectra AB
STO:SECT B
|
Cost of Revenue
-kr910.1m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
K
|
Kontigo Care AB
STO:KONT
|
Cost of Revenue
-kr10m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-134%
|
CAGR 10-Years
N/A
|
|
Ortivus AB
Glance View
Ortivus AB engages in the development and sale of clinical devices and systems. The company is headquartered in Danderyd, Stockholm. The firm is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Company’s customer base includes mainly ambulance services and emergency departments.
See Also
What is Ortivus AB's Cost of Revenue?
Cost of Revenue
-53.2m
SEK
Based on the financial report for Dec 31, 2023, Ortivus AB's Cost of Revenue amounts to -53.2m SEK.
What is Ortivus AB's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-12%
Over the last year, the Cost of Revenue growth was 5%. The average annual Cost of Revenue growth rates for Ortivus AB have been 8% over the past three years , -12% over the past five years .
You don't have any saved screeners yet
